Notably, amlodipine selectively induces the autophagic degradation of PD-L1 in a calcium-dependent manner, reducing PD-1 binding, increasing T-cell cytotoxicity, suppressing tumor growth, and improving the effectiveness of anti-PD-L1 therapy in preclinical models [99]. This evidence concerns the gene CD274 and neoplasm.